HIGHLIGHTS
- who: Sophie Servais and collaborators from the University Hospital Frankfurt, Germany have published the research work: Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis, in the Journal: (JOURNAL)
- what: And administration For this study, MSCs were collected from the BM (50 u00b1 10mL) of 13 third-party healthy volunteer donors (11 men and 2 women) at the CHU of Liu00e8ge (Liu00e8ge, Belgium) between 2007 and 2012. The study provides encouraging results on the efficacy and safety of MSC-based therapy for PGF and prolonged . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.